Business Standard

Natco Pharma Q2 net profit rises 73% to Rs 204 crore on robust sales

Consolidated total income of the company stood at Rs 827.9 crore for the quarter under consideration

Q2 company results

Illustration by Ajay Mohanty

Press Trust of India New Delhi
Drug firm Natco Pharma on Thursday reported a 73.23 per cent increase in its consolidated net profit to Rs 203.9 crore for the quarter ended September mainly on account of robust sales.
The company had posted a net profit of Rs 117.7 crore for the corresponding period of the previous fiscal, Natco Pharma said in a BSE filing.
Consolidated total income of the company stood at Rs 827.9 crore for the quarter under consideration. It was Rs 518.9 crore for the same period a year ago, it added.
The board of directors has recommended a second interim dividend of Rs 3 per equity share of Rs 2 each for the financial year 2020-21, the filing said.
Shares of Natco Pharma were trading at Rs 902.00 per scrip on BSE, up 0.52 per cent from its previous close.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Nov 12 2020 | 5:06 PM IST

Explore News